Carbon Silicon Ventures

Carbon Silicon Ventures, founded in 2022 and based in New York City, is a venture capital firm that invests in early-stage companies at the cutting edge of biotechnology and healthcare. With a focus on pre-seed, seed, and Series A rounds, the firm aims to back startups applying engineering and scalable technologies to revolutionize life sciences. The firm's primary sectors include lab automation, drug development, and biotech SaaS, targeting companies that use innovative methods to disrupt the healthcare landscape. Led by Nish Bhat, co-founder of Color, Carbon Silicon Ventures is deeply embedded in the biotech community, leveraging Bhat's experience in healthcare and technology to identify promising startups. The firm has already made significant investments in companies like Ansa Biotechnologies, known for its breakthroughs in synthetic biology, and Octant Bio, a leader in drug discovery​. Carbon Silicon Ventures typically writes checks ranging from $100K to $500K and focuses on U.S.-based companies. It positions itself as a high-conviction investor, supporting founders that aim to scale transformative solutions. The firm has a growing portfolio that includes promising biotech startups, aligning itself with major co-investors like Sequoia and Andreessen Horowitz. With a clear mission to apply engineering principles to healthcare, Carbon Silicon Ventures is well-positioned to make a lasting impact on the future of medicine.